MBRX logo

Moleculin Biotech (MBRX) Current Liabilities

Annual Current Liabilities

$6.82 M
+$2.00 M+41.42%

December 31, 2023


Summary


Performance

MBRX Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMBRXbalance sheetmetrics:

Quarterly Current Liabilities

$5.59 M
-$153.00 K-2.66%

September 30, 2024


Summary


Performance

MBRX Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMBRXbalance sheetmetrics:

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

MBRX Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+41.4%+3.4%
3 y3 years+133.4%-14.7%
5 y5 years+75.7%-14.7%

MBRX Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+88.2%-17.9%+54.4%
5 y5-yearat high+133.4%-17.9%+91.5%
alltimeall timeat high+781.9%-49.7%+471.9%

Moleculin Biotech Current Liabilities History

DateAnnualQuarterly
Sep 2024
-
$5.59 M(-2.7%)
Jun 2024
-
$5.75 M(+6.3%)
Mar 2024
-
$5.41 M(-20.6%)
Dec 2023
$6.82 M(+41.4%)
$6.82 M(+75.3%)
Sep 2023
-
$3.89 M(-40.7%)
Jun 2023
-
$6.55 M(+30.2%)
Mar 2023
-
$5.03 M(+4.4%)
Dec 2022
$4.82 M(+33.0%)
$4.82 M(-24.3%)
Sep 2022
-
$6.36 M(+8.6%)
Jun 2022
-
$5.86 M(+21.2%)
Mar 2022
-
$4.83 M(+33.5%)
Dec 2021
$3.62 M(+24.0%)
$3.62 M(-0.9%)
Sep 2021
-
$3.66 M(+9.1%)
Jun 2021
-
$3.35 M(-26.8%)
Mar 2021
-
$4.58 M(+56.8%)
Dec 2020
$2.92 M
$2.92 M(-15.1%)
Sep 2020
-
$3.44 M(-8.1%)
Jun 2020
-
$3.74 M(+15.6%)
DateAnnualQuarterly
Mar 2020
-
$3.23 M(-9.4%)
Dec 2019
$3.57 M(-7.9%)
$3.57 M(-67.9%)
Sep 2019
-
$11.12 M(+15.9%)
Jun 2019
-
$9.59 M(+49.0%)
Mar 2019
-
$6.44 M(+66.0%)
Dec 2018
$3.88 M(+75.1%)
$3.88 M(+23.9%)
Sep 2018
-
$3.13 M(-24.0%)
Jun 2018
-
$4.12 M(+128.8%)
Mar 2018
-
$1.80 M(-18.8%)
Dec 2017
$2.21 M(+64.7%)
$2.21 M(+20.9%)
Sep 2017
-
$1.83 M(+0.1%)
Jun 2017
-
$1.83 M(-17.0%)
Mar 2017
-
$2.20 M(+63.9%)
Dec 2016
$1.34 M(+74.0%)
$1.34 M(+5.1%)
Sep 2016
-
$1.28 M(-8.7%)
Jun 2016
-
$1.40 M(+43.4%)
Mar 2016
-
$978.00 K
Dec 2015
$772.80 K
-

FAQ

  • What is Moleculin Biotech annual total current liabilities?
  • What is the all time high annual current liabilities for Moleculin Biotech?
  • What is Moleculin Biotech annual current liabilities year-on-year change?
  • What is Moleculin Biotech quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Moleculin Biotech?
  • What is Moleculin Biotech quarterly current liabilities year-on-year change?

What is Moleculin Biotech annual total current liabilities?

The current annual current liabilities of MBRX is $6.82 M

What is the all time high annual current liabilities for Moleculin Biotech?

Moleculin Biotech all-time high annual total current liabilities is $6.82 M

What is Moleculin Biotech annual current liabilities year-on-year change?

Over the past year, MBRX annual total current liabilities has changed by +$2.00 M (+41.42%)

What is Moleculin Biotech quarterly total current liabilities?

The current quarterly current liabilities of MBRX is $5.59 M

What is the all time high quarterly current liabilities for Moleculin Biotech?

Moleculin Biotech all-time high quarterly total current liabilities is $11.12 M

What is Moleculin Biotech quarterly current liabilities year-on-year change?

Over the past year, MBRX quarterly total current liabilities has changed by +$185.00 K (+3.42%)